In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
A growing body of research underscores that Alzheimer’s and cognitive decline are not inevitable parts of aging.
Gautam Singh is the Business Unit Head of WNS Analytics and the Co-founder & CEO of The Smart Cube, a WNS Company. He spent ...
As with most foods, ‘in moderation’ applies here. As part of a balanced diet, porridge oats are perfectly healthy, but if you ...
I don’t use the word lightly, and I don’t use it provocatively. I use it factually when I observe that many of Trump’s ...
The AI platform Clarifai has launched a new reasoning engine that it claims will make running AI models twice as fast and 40% ...
The Parallel-R1 framework uses reinforcement learning to teach models how to explore multiple reasoning paths at once, ...
They found that when the tasks were not in the training data, the language model failed to achieve those tasks correctly using a chain of thought. The AI model tried to use tasks that were in its ...
GKN Aerospace is to expand its factory in Newington, Connecticut, adding a new additive fabrication capability to build parts for Pratt & Whitney PW1500G and PW1900G engines. UK-headquartered GKN ...
“From reasoning improvements to slow, deep thinking and multimodal abilities, [our] model’s performance and efficiency have increased,” Wang said. The X1.1 model showed a 34.8 per cent improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results